Recent press reports and other evidence suggest that Medicare Part D plans may be encouraging the use of brand-name drugs instead of generics. However, the scope of such practices is unclear. We ...

Annabelle C. Fowler, Charles River Associates, Boston, Massachusetts. Ruben Jacobo-Rubio, Food and Drug Administration, Silver Spring, Maryland. Jing Xu ([email protected]), Food and Drug ...

A new court ruling has the future use of skinny labels in question, but skinny-label generics have saved Medicare a lot of money over 5 years. Skinny labels, which carve out patent-protected ...

Consumers and lawmakers pushing for cheaper alternatives to the EpiPen, an antidote for life-threatening allergic reactions, and other high-priced drugs are seeking answers about a stubborn backlog of ...